The global Sepsis Treatment Market, valued at over US$ 600 million in 2020, is projected to reach US$ 1.6 billion by 2031, expanding at a robust compound annual growth rate (CAGR). Sepsis, a life-threatening condition caused by the body's response to infection, requires treatments like antibiotics, corticosteroids, and supportive care. The market's

The global Halal and Kosher Empty Capsules Market, valued at US$ 1.4 billion in 2021, is projected to grow robustly, expanding at a compound annual growth rate (CAGR) of 8.0% from 2022 to 2031, reaching more than US$ 2.9 billion by the end of the forecast period. These capsules, made from gelatin or plant-based materials certified as halal or koshe

The global Neurological Disorder Drugs Market is projected to reach approximately US$ 112 billion by 2027, expanding at a modest compound annual growth rate (CAGR) of approximately 5% during the forecast period. This market encompasses pharmaceuticals for treating disorders like epilepsy, Alzheimer's, Parkinson's, multiple sclerosis, and migraines.

The global Lyme Disease Treatment Market is projected to reach US$ 3 billion by 2031, expanding at a compound annual growth rate (CAGR) of approximately 6% from 2021 to 2031. Lyme disease, caused by Borrelia burgdorferi and transmitted through tick bites, requires treatments like antibiotics (e.g., doxycycline, amoxicillin) and, in severe cases, in

The global Adrenocorticotropic Hormone (ACTH) Market, valued at US$ 1.3 billion in 2020, is projected to expand at a compound annual growth rate (CAGR) of 3.9% from 2021 to 2031. ACTH, a hormone used in diagnostic tests and treatments for adrenal disorders like Addison's disease and Cushing's syndrome, plays a critical role in managing endocrine co